Qiming Venture Partners
Qiming Venture Partners is a venture capital firm investing in the TMT and healthcare industries at the early and growth stages.
Business Model:
Revenue: $8.1M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Qiming Venture Partners Information
Geographic Data
Address: Room3906 Jinmao Tower
City: Shanghai
State: shanghai municipality
Zip: 200121
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$9B
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
2,312,265Website Global Rank
8,132Website Monthly Traffic
Twitter Followers
Description
Qiming Venture Partners is a venture capital firm that specializes in building new companies in China. Since their establishment, they have been investing in the TMT and healthcare industries at the early and growing stages. Founded in 2006 by Gary Rieschel, Qiming Venture Partners based in Shanghai, Shanghai.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2013 | Cehome | Series A | 2M |
| 6/2011 | Novast | Series C | 2.9M |
| 5/2021 | MeetFuture China | Series A | 12.3M |
| 1/2021 | Oricell Therapeutics | Series A | 0 |
| 4/2015 | HaiRun Pictures | Series A | 11.3M |
| 11/2010 | Guokang Health Management | Series B | 14.9M |
| 1/2021 | RFoneTech | Series A | 4.6M |
| 7/2019 | Chuman | Series B | 8.7M |
| 8/2019 | Haoyiku | Series C | 100M |
| 10/2021 | Clounix | Seed Round | 34.9M |
| 10/2016 | Broncus Technologies | Series A | 12.2M |
| 12/2017 | Xiaobu | Series B | 14M |
| 10/2017 | Gaiya Environment | Series A | 6.1M |
| 4/2015 | Fortune International Factoring | Series A | 16.2M |
| 5/2018 | Hanqi | Series A | 6.3M |
| 11/2017 | Chuman | Series A | 8.3M |
| 5/2021 | Render | Series A | 15.5M |
| 8/2018 | Plum | Series B | 21.4M |
| 9/2011 | Novast | Series D | 2M |
| 4/2017 | IntoCare | Series A | 26M |
| 12/2011 | Appconomy | Series B | 10M |
| 12/2021 | InfStones | Series B | 33M |
| 6/2017 | SinoTau | Series B | 22M |
| 9/2009 | 60DXchange | Venture Round | - |
| 2/2021 | Morewis | Series B | 9.3M |
| 2/2021 | Singular Medical | Series B | 24M |
| 4/2017 | CanSinoBIO | Series E | 0 |
| 4/2021 | P&a;R Measurement Technology | Series C | 23.9M |
| 2/2018 | P&a;R Measurement Technology | Series A | 9.9M |
| 7/2010 | LanzaTech | Series B | 18M |
| 12/2019 | Oricell Therapeutics | Seed Round | 14.2M |
| 12/2021 | TUNGEE | Series B | 0 |
| 1/2020 | DST Car | Series C | - |
| 8/2018 | Kira Pharmaceuticals | Series A | 13M |
| 8/2016 | Ruhnn Holding Limited | Series C | - |
| 11/2020 | LaNova Medicines | Series A | 84.4M |
| 10/2018 | DST Car | Series B | 47.4M |
| 3/2022 | MeetFuture China | Series B | 0 |
| 3/2020 | Singular Medical | Series A | 10M |
| 3/2016 | Cehome | Series C | 25M |
| 1/2017 | Diandoc | Seed Round | 1M |
| 7/2020 | Antengene Corporation | Series C | 97M |
| 9/2017 | TigerGraph | Series A | 31M |
| 9/2009 | Jiayuan | Series B | - |
| 9/2015 | Oakbarrel | Series B | 3.1M |
| 10/2010 | Dang Le | Series A | 12M |
| 5/2018 | Xueba100.com | Series D | 22.5M |
| 2/2009 | Youxigu | Series A | - |
| 11/2018 | Eigen | Series B | 6.6M |
| 2/2017 | LIH Investment &a; Management | Series A | 5.8M |
| 12/2018 | Try Try | Series A | 7M |
| 7/2020 | 52toys | Secondary Market | 2M |
| 4/2016 | AirQuality | Series B | 4M |
| 6/2016 | JunHe | Series B | 7.6M |
| 3/2019 | 52toys | Series A | 447.3k |
| 3/2018 | 52toys | Series A | 14.6M |
| 4/2020 | DiNovA Medtech | Series C | 17M |
| 4/2017 | ByteDance | Series D | 1B |
| 12/2020 | dMed | Series C | 100M |
| 7/2021 | Hochuen Medical Technology | Series A | 6.2M |
| 12/2016 | dMed | Series A | 8M |
| 10/2012 | MOGU | Series C | - |
| 1/2012 | MOGU | Series B | 10M |
| 4/2017 | ZappRx | Series B | 25M |
| 4/2018 | ZD Medical | Series A | 16.7M |
| 7/2018 | The Good Stuff | Series B | 50M |
| 11/2021 | Genlight | Series B | 31.4M |
| 8/2014 | Lagou | Series B | 25M |
| 12/2015 | Aerospace Environment | Series A | 1.3M |
| 6/2019 | Pulsar Technology | Series A | - |
| 10/2021 | Brise Pharma | Angel Round | 0 |
| 11/2010 | Docin | Series B | - |
| 12/2008 | Docin | Series A | 1M |
| 3/2018 | Bouffalo Lab | Series A | 7M |
| 6/2017 | Chaitin Tech | Series A | 4M |
| 12/2016 | CETA | Series A | 4.4M |
| 1/2020 | Sunny Dental | Series A | 28.7M |
| 6/2015 | Financial Information Management | Series A | 6M |
| 12/2019 | Chaodian Culture | Series B | 150M |
| 12/2018 | Chaodian Culture | Series A | 5.5M |
| 8/2020 | Shukun Technology | Series B | 0 |
| 10/2017 | Castbox | Series A | 12.8M |
| 9/2013 | Tiangua Online | Series B | 1M |
| 3/2016 | CashBUS | Series B | 25M |
| 5/2021 | Just Medical | Series B | 34M |
| 1/2018 | Innostic | Series A | 39.5M |
| 4/2021 | Xizi Education | Series A | 22M |
| 10/2015 | JFK Biotech | Angel Round | 472.7k |
| 8/2019 | Bondent Technology | Series D | - |
| 6/2020 | Shukun Technology | Series B | 0 |
| 3/2021 | Fucunbao | Series C | 11.4M |
| 12/2009 | CITIC Pharmaceutical | Series D | 1M |
| 6/2018 | RENS Energy | Angel Round | 1M |
| 9/2019 | Yunyinggu | Series C | 22M |
| 2/2015 | Aerospace Environment | Series A | - |
| 9/2021 | GYENNO Technologies | Series B | 17.3M |
| 1/2015 | Transwarp | Series A | 5.1M |
| 6/2022 | LaNova Medicines | Series B | - |
| 10/2016 | APT Medical | Series A | 3.6M |
| 8/2019 | APT Medical | Venture Round | 27.2M |
| 11/2018 | APT Medical | Series C | 19.2M |
| 10/2012 | CooTek | Series B | 8.2M |
| 7/2017 | Kuaile Zhihui | Series A | 0 |
| 4/2020 | New Horizon Health | Series D | 20M |
| 2/2016 | Transwarp | Series B | 23.6M |
| 11/2020 | Kira Pharmaceuticals | Venture Round | - |
| 3/2015 | Ark Biosciences | Series A | - |
| 11/2021 | Suci Technology | Series A | 8.3M |
| 6/2021 | Insilico Medicine | Series C | 0 |
| 6/2011 | Domob | Series B | 20M |
| 12/2015 | Nurotron Biotechnology | Series C | - |
| 4/2018 | Castbox | Series B | 13.5M |
| 4/2020 | Yunyinggu | Series C | 28.2M |
| 10/2015 | Luoji Siwei | Series B | - |
| 5/2021 | Hope Medicine | Series B | 56M |
| 11/2021 | Shanzhen | Series D | 17M |
| 4/2021 | Sincere Edu | Series A | 13M |
| 4/2020 | Chuhang Tech | Series A | 6.4M |
| 9/2019 | Shanzhen | Series D | 30M |
| 5/2022 | AskGene Pharma | Series A | 20M |
| 12/2018 | YI Technology | Venture Round | 10M |
| 4/2012 | Dang Le | Series B | 20M |
| 7/2016 | UBTech Robotics | Series B | 100M |
| 4/2015 | UBTech Robotics | Series A | - |
| 11/2021 | Atom Semiconductor | Venture Round | 12M |
| 11/2020 | Nice Tuan | Series C | 0 |
| 5/2011 | Crown Bioscience | Venture Round | 1M |
| 5/2015 | MedSci | Series A | 14.9M |
| 3/2020 | NVX Clouds Tech | Series A | 3.9M |
| 7/2020 | TUNGEE | Series B | 17.2M |
| 8/2019 | Webuy Group | Series C | 100M |
| 8/2018 | Chaodian Culture | Angel Round | - |
| 4/2020 | Pratilipi | Series C | 0 |
| 4/2018 | Miaoshou Doctor | Series C | 79.6M |
| 6/2017 | Meituan Bike | Series E | 600M |
| 4/2022 | Onechip Bioelectronics | Series B | 23.5M |
| 9/2016 | Meituan Bike | Series C | - |
| 11/2020 | ZEGOCLOUD | Venture Round | 50M |
| 1/2021 | Yunji Technology | Series C | 0 |
| 9/2018 | Tuhu | Series E | 0 |
| 1/2017 | Meituan Bike | Series D | 215M |
| 3/2021 | Hangzhou Weier | Series B | 15.5M |
| 2/2022 | BUD | Series A | 15M |
| 5/2015 | Tongdun Technology | Series B | 30M |
| 12/2009 | ChinaCache | Series D | - |
| 1/2012 | Timesafer | Series A | - |
| 4/2007 | ChinaCache | Series B | 31.5M |
| 9/2015 | Roborock | Angel Round | - |
| 4/2021 | Tasogare | Series B | 41.1M |
| 3/2016 | SharpSpring | Post-IPO Equity | - |
| 5/2019 | Chuhang Tech | Series A | 4.5M |
| 8/2017 | ARMO BioSciences | Series C | 0 |
| 5/2021 | TUNGEE | Venture Round | 148M |
| 11/2021 | Zeen Health | Venture Round | 6.3M |
| 12/2013 | Nurotron Biotechnology | Series C | 16.2M |
| 12/2017 | Mafengwo | Series D | 133M |
| 4/2018 | Chaodian Culture | Series A | 12.6M |
| 3/2007 | PPS | Series B | 10M |
| 6/2007 | ICE Entertainment | Series A | 8.5M |
| 3/2021 | Newsoara | Series C | 7M |
| 7/2022 | Biotree | Series A | 13.3M |
| 7/2018 | AI Prime | Angel Round | 1M |
| 6/2020 | OriginCell | Series A | 8.4M |
| 10/2018 | Akulaku | Series C | 0 |
| 7/2018 | Core Medical | Series A | 4.4M |
| 5/2019 | New Horizon Health | Series C | 0 |
| 6/2020 | Biren Technology | Series A | 0 |
| 12/2016 | Cencorp Automation | Series A | 10.5M |
| 7/2012 | Beijing Centre Biology | Series B | 2.6M |
| 10/2019 | Casela | Series A | 16.7M |
| 3/2021 | Medilink Therapeutics | Series A | 50M |
| 4/2016 | FraudMetrix | Series C | - |
| 9/2022 | Supervision Technology | Seed Round | - |
| 1/2022 | Deep View Technology | Series B | - |
| 5/2021 | Yidao Biotechnology | Series C | 61.8M |
| 6/2015 | Shenogen Pharma Group | Series D | 2.1M |
| 11/2021 | Tripod Preclinical Research Laboratories | Venture Round | 0 |
| 5/2017 | Jisuyun | Series A | 7.4M |
| 3/2019 | Insta360 | Series C | 0 |
| 12/2019 | DiNovA Medtech | Series C | 24.6M |
| 11/2019 | Liuyi Jiaoyu | Series B | 0 |
| 7/2022 | CIX Technology | Seed Round | - |
| 5/2019 | LetsGetChecked | Series B | 0 |
| 7/2021 | Liangyihui | Series C | 55.9M |
| 9/2019 | Insilico Medicine | Series B | 37M |
| 6/2020 | Kingsware | Series A | 14.7M |
| 3/2021 | Delta Medical | Series E | 20.1M |
| 8/2019 | Delta Medical | Series C | 7.1M |
| 6/2016 | AIQI Technology | Venture Round | 7M |
| 8/2015 | Linjia.me | Series B | - |
| 5/2022 | Point One | Series B | 36.8M |
| 9/2021 | XSKY Data Technology | Series E | 0 |
| 11/2019 | Nice Tuan | Series B | 60.4M |
| 12/2016 | ANXIN | Series B | 42.7M |
| 12/2021 | Gemsouls | Series A | 4M |
| 4/2012 | ITutorGroup | Series A | 15M |
| 1/2021 | Erwan Technology | Series D | - |
| 10/2021 | Cubenergy Technology | Series A | - |
| 3/2021 | YUANBAO TECH | Series C | 80M |
| 2/2021 | Plum | Series B | 9.1M |
| 8/2012 | CooTek | Series A | 4.2M |
| 5/2017 | CANbridge Pharmaceuticals | Series B | 25M |
| 1/2022 | MKSEMI | Pre-Series A | 12.8M |
| 8/2019 | Huimei Technology | Series C | 30M |
| 8/2021 | WeRide | Secondary Market | 2M |
| 12/2014 | LanzaTech | Series D | 0 |
| 11/2013 | LanzaTech | Series C | 0 |
| 5/2015 | Coohua | Series B | 20M |
| 8/2017 | ABC Fintech | Series A | 30M |
| 7/2015 | Bilibili | Series C | 161.4M |
| 3/2021 | Casela | Series A | 2.8M |
| 10/2016 | Bondent Technology | Series A | 9M |
| 3/2021 | MediLink-Global | Series A | 36.9M |
| 9/2007 | Gaoxing Co., Ltd | Series A | - |
| 3/2020 | Berry Oncology | Series A | 10M |
| 10/2013 | Unisound | Series A | 16.3M |
| 1/2021 | Cornerstone Robotics | Series A | 17M |
| 12/2021 | PoPop World | Seed Round | 0 |
| 1/2015 | APUS Group | Series B | 100M |
| 6/2013 | Venus MedTech | Series A | 17M |
| 11/2006 | Kuwo Science and Technology | Series A | 5.5M |
| 2/2022 | Purui | Seed Round | 15.7M |
| 5/2011 | Gan &a; Lee Pharmaceutical | Series B | 30.2M |
| 4/2021 | ZSHK Laboratories | Series A | 15.5M |
| 2/2012 | Gan &a; Lee Pharmaceutical | Series B | - |
| 8/2010 | BTR | Series A | 1.6M |
| 1/2020 | DST Car | Series C | - |
| 8/2018 | CureGenetics | Series A | 17M |
| 9/2017 | Zaojiu | Series A | 5.2M |
| 3/2018 | Zaojiu | Series A | 4.7M |
| 12/2019 | Woof | Series A | 7M |
| 12/2018 | Woof | Series A | 5.8M |
| 4/2017 | Bomming Vision | Series A | 4.4M |
| 1/2018 | Bomming Vision | Series A | 1.5M |
| 1/2019 | V Light | Series A | 2.5M |
| 9/2021 | V Light | Series A | 7M |
| 5/2018 | Tisenc | Series A | 6.3M |
| 5/2014 | VINNO Technology | Series B | 7.7M |
| 6/2009 | Taomee | Series A | - |
| 2/2023 | Hochuen Medical Technology | Series B | - |
| 12/2007 | Topone | Series C | 50M |
| 3/2005 | b2c.cn | Series A | 3M |
| 10/2014 | Coohua | Series A | 4.9M |
| 9/2019 | QwikMatch | Debt Financing | 1.4M |
| 1/2007 | Tianyuan Bio-Pharmaceutical | Series A | - |
| 5/2018 | Philm | Series B | 7M |
| 9/2021 | PlusLife Biotech | Series A | 14.9M |
| 7/2021 | NEIWAI | Series D | 100M |
| 10/2019 | NEIWAI | Series C | 18M |
| 3/2013 | JHT TCM Clinics | Series A | 2.2M |
| 10/2018 | WeRide | Series A | - |
| 3/2015 | BBI Life Sciences | Post-IPO Equity | 10.3M |
| 2/2015 | Helijia | Series C | 50M |
| 4/2015 | Zai Lab | Series A | 18.3M |
| 8/2022 | Insilico Medicine | Series D | 35M |
| 5/2017 | ET Healthcare | Venture Round | 7M |
| 3/2019 | Gohoo | Series A | 10.6M |
| 11/2015 | Zhihu | Series C | 55M |
| 11/2019 | 61Draw.com | Series B | 11M |
| 1/2017 | CooTek | Series D | 66M |
| 8/2013 | LP Amina | Series C | 20M |
| 1/2023 | Insyce | Series B | 21.8M |
| 1/2017 | Bondent Technology | Series B | - |
| 11/2021 | Cornerstone Robotics | Series B | 0 |
| 8/2019 | TUNGEE | Series B | 17.7M |
| 1/2021 | Erwan Technology | Series E | - |
| 10/2019 | Club Factory | Series D | 100M |
| 2/2008 | Ether Optronics (Suzhou) Co., Ltd. | Venture Round | - |
| 9/2017 | SinoVision Technologies | Series B | 29M |
| 2/2014 | VANCL | Series G | 100M |
| 7/2017 | Qiagen Suzhou Translational Medicine | Series A | 0 |
| 7/2015 | OneAPM | Series C | 26.7M |
| 3/2018 | Infervision | Series B | 47.4M |
| 1/2015 | Mitralign | Series E | 23M |
| 5/2022 | Yike Polymers | Series B | - |
| 6/2019 | 61Draw.com | Series B | 28M |
| 7/2018 | Lanjinrong | Series C | 11.6M |
| 9/2021 | Alamar Biosciences | Series B | 80M |
| 6/2018 | IDsManager | Series A | 7.8M |
| 5/2021 | Insight Lifetech | Secondary Market | 18.1M |
| 12/2021 | Wholee | Series B | 69M |
| 2/2022 | NFTGo | Pre-Series A | 6.8M |
| 5/2020 | Nice Tuan | Series C | 0 |
| 7/2017 | Bingobox | Series A | 14.7M |
| 2/2013 | Tujia | Series B | 40M |
| 1/2022 | Axera | Series A | 0 |
| 11/2018 | Chushou | Venture Round | 8.4M |
| 1/2018 | Bingobox | Series B | 0 |
| 9/2016 | Zuiyou | Series B | 53M |
| 1/2017 | Chushou | Series C | 57.6M |
| 5/2013 | CSD E.P. Water Service | Series B | - |
| 4/2022 | LTZ Therapeutics | Pre-Series A | 17M |
| 6/2015 | Zhejiang JFK | Angel Round | - |
| 5/2022 | Ashermed | Series B | - |
| 6/2008 | LP Amina | Series A | 5M |
| 5/2020 | Microtech Medical | Venture Round | 20M |
| 4/2021 | ET Healthcare | Series G | 105M |
| 9/2017 | Lagou | Series D | 119.2M |
| 11/2018 | Chomp Cloud | Series B | 13.3M |
| 9/2019 | Platelet BioGenesis | Series A | 26M |
| 9/2020 | Delta Medical | Series D | - |
| 4/2014 | Laguo | Series A | 5M |
| 10/2017 | WeRide | Seed Round | - |
| 8/2014 | Zai Lab | Series A | 10M |
| 6/2014 | Zhihu | Series B | 22M |
| 1/2023 | Tingsheng Technology | Series B | 14.7M |
| 7/2017 | AFU | Series C | 9.3M |
| 10/2018 | DST Car | Series B | 43.1M |
| 9/2017 | Infervision | Series B | 18.2M |
| 6/2018 | Alpha Biopharma | Series A | 37M |
| 5/2009 | Touchmedia | Series B | 16.2M |
| 10/2021 | Qingflow | Series B | 11.8M |
| 4/2020 | Shulan Health | Series C | 8.5M |
| 8/2017 | SceneRay | Series C | 19.1M |
| 7/2014 | Beijing Richen-Force Science &a; Technology | Series B | 4.5M |
| 12/2021 | Xinchuangyuan Semiconductor | Series A | 75.4M |
| 12/2021 | Yunji Technology | Venture Round | 72.2M |
| 3/2020 | Berry Genomics | Post-IPO Equity | 10M |
| 9/2018 | ET Healthcare | Series C | 17.5M |
| 12/2015 | UBTech Robotics | Series A | 20M |
| 8/2016 | Xiaoman Technology | Series B | 5.3M |
| 12/2019 | Vongi | Series B | 2.9M |
| 8/2010 | 2Duche | Venture Round | - |
| 12/2017 | Eigen | Series B | 18.5M |
| 1/2008 | Crown Bioscience | Venture Round | - |
| 9/2019 | DST Car | Venture Round | 30M |
| 3/2018 | Frontage Laboratories | Funding Round | 32.4M |
| 5/2021 | Wonderful | Secondary Market | 1.4M |
| 9/2018 | Bion Interactive Entertainment Company | Seed Round | 2M |
| 3/2008 | Crown Bioscience | Series B | 3.2M |
| 4/2018 | Bondent Technology | Series C | 12.7M |
| 1/2012 | Qiniu | Series A | - |
| 3/2020 | IntoCare | Series C | 7M |
| 8/2018 | PangQiu | Series A | 6.1M |
| 7/2019 | OneAPM | Venture Round | 1.6M |
| 1/2018 | Berry Genomics | Post-IPO Equity | 122.7M |
| 6/2013 | Iron Armour | Series A | 5M |
| 8/2021 | Houmo.AI | Seed Round | 46M |
| 11/2012 | YPX Cayman Holdings | Series C | 0 |
| 2/2019 | Nuvaira | Equity | 79M |
| 7/2016 | CooTek | Series D | 46M |
| 6/2019 | ZD Medical | Series A | 4.5M |
| 9/2018 | IntoCare | Series B | 3.7M |
| 6/2014 | Inbilin | Series A | 15M |
| 5/2017 | XSKY Data Technology | Series B | 17.4M |
| 3/2020 | CureGenetics | Series A | 9.5M |
| 11/2007 | Dining Secretary | Series B | - |
| 7/2018 | Zuiyou | Series C | 22M |
| 7/2021 | Kingsware | Series B | 42.4M |
| 9/2021 | Genevide | Angel Round | 6M |
| 5/2021 | MKSEMI | Series A | 12.9M |
| 4/2019 | WebComics | Venture Round | 785k |
| 9/2021 | moodytiger | Series B | 20M |
| 8/2018 | CANbridge Pharmaceuticals | Series C | 38.1M |
| 3/2014 | Domob | Series C | 2M |
| 1/2010 | eHi Car Rental | Series B | 18.7M |
| 7/2019 | Xiudan | Seed Round | - |
| 1/2019 | Zion Pharma | Series A | 11.9M |
| 8/2020 | Zion Pharma | Series A | 20M |
| 4/2019 | Anxin Doctor | Series B | 3.6M |
| 12/2014 | Unisound | Series B | 50M |
| 2/2015 | Amoy Diagnostics | Series A | 10.7M |
| 4/2017 | Berry Genomics | Funding Round | 8.1M |
| 1/2014 | VR Medical | Series A | 5.5M |
| 6/2009 | Alltech Medical Systems | Series B | 5M |
| 3/2008 | eHi Car Rental | Series A | 5M |
| 5/2017 | Jisuyun | Series A | 7.4M |
| 7/2015 | CMLabs | Series A | 1.1M |
| 1/2016 | 8kana | Series A | 6M |
| 3/2010 | Tigermed | Venture Round | 2M |
| 9/2006 | Alltech Medical Systems | Series A | - |
| 2/2014 | Wacai.com | Series A | 15M |
| 2/2019 | Xiaobu | Series B | 12M |
| 4/2019 | Bomming Vision | Series A | 596k |
| 7/2016 | KingTrol Data | Series A | 4.5M |
| 3/2016 | SMTP Technology | Series A | 3.1M |
| 11/2015 | Shanghai Keysino Separation Technology | Series A | 7.9M |
| 1/2015 | Zhaolu Tianxia Wang | Series A | 1.6M |
| 7/2016 | Junhetang | Series B | 7.9M |
| 12/2010 | wali | Series A | 4.6M |
| 1/2016 | AIQI Technology | Series A | - |
| 11/2016 | Chomp Cloud | Series A | 6M |
| 7/2014 | CooTek | Series C | 69.3M |
| 4/2014 | APT Medical | Series A | - |
| 3/2011 | CSD Beijing Water Affairs Op | Venture Round | - |
| 6/2014 | Ants Technology | Series B | 7M |
| 6/2009 | ConvenientPower HK | Series A | 3M |
| 9/2017 | Sino Vision | Series B | 30.6M |
| 9/2014 | Tuhu | Series B | 10M |
| 3/2019 | Emergen | Series B | 29.8M |
| 8/2011 | Arrail Dental Clinic | Series B | 20M |
| 1/2018 | Roborock | Series B | 3.4M |
| 3/2020 | Wuli Planet | Series A | 7.5M |
| 6/2018 | Wuli Planet | Seed Round | 2M |
| 5/2014 | Ants Technology | Series A | 3.5M |
| 3/2016 | Shanghai Rendu Biotechnology | Series B | 2.3M |
| 4/2016 | Roborock | Series B | 25M |
| 8/2018 | Jacobio Pharmaceuticals | Series C | 0 |
| 1/2017 | Connect Biopharmaceuticals | Series A | 20M |
| 7/2018 | Kaiheikeji Digital | Series A | 15M |
| 3/2021 | Zhenge Biotech | Series B | 70M |
| 7/2016 | Chaitin Tech | Series A | 4.1M |
| 11/2017 | Kaiheikeji Digital | Series A | 11.5M |
| 1/2011 | CSD E.P. Water Service | Venture Round | - |
| 12/2020 | Compart Systems | Venture Round | 398M |
| 11/2016 | Yinshiji | Series A | - |
| 1/2014 | Tuhu | Series B | - |
| 2/2020 | Fingo | Series A | 7M |
| 4/2017 | Qiang Sen International Community Medical | Series B | 14.6M |
| 1/2018 | Chaodian Culture | Seed Round | 723.8k |
| 10/2018 | DK MedTech | Series B | 8.7M |
| 8/2010 | Jiayuan | Series B | - |
| 8/2019 | WorkTrans | Series C | 50.5M |
| 5/2015 | Junhetang | Series B | - |
| 9/2011 | Slanissue | Venture Round | 10M |
| 5/2019 | Hesai Technology | Series C | 37M |
| 9/2016 | Hypereal | Series B | 10.5M |
| 8/2022 | Prismlab China Ltd | Series C | 29.1M |
| 7/2020 | HashQuark | Series A | 2M |
| 2/2010 | Aeonmed Medical Treatment | Series A | 3.5M |
| 10/2017 | Moretickets | Series B | 25M |
| 6/2017 | Platelet BioGenesis | Series A | 0 |
| 9/2016 | OneAPM | Series D | 19.5M |
| 4/2016 | CanSinoBIO | Venture Round | 11M |
| 5/2008 | Kuwo Science and Technology | Series B | - |
| 3/2018 | Jisuyun | Series B | 11.4M |
| 12/2009 | Gan &a; Lee Pharmaceutical | Series A | 16.2M |
| 11/2018 | Reelsky Data Systems | Series A | 5.4M |
| 5/2019 | Mafengwo | Series E | 0 |
| 9/2021 | Sanegene Bio | Series A | 38M |
| 2/2020 | Jacobio Pharmaceuticals | Series C | 27M |
| 7/2014 | Intelligent Automation | Series B | 4.2M |
| 4/2021 | ROX Motor | Series A | 60M |
| 4/2009 | Kaixin001 | Series B | 20M |
| 6/2016 | VeeR (Velocious) | Seed Round | 2M |
| 12/2018 | FirstGrid | Seed Round | 4.8M |
| 1/2008 | PPS | Series C | 20M |
| 1/2018 | Xiaoman Technology | Series C | 9.7M |
| 4/2016 | Tongdun Technology | Series B | 32M |
| 11/2018 | Haoyiku | Series B | - |
| 8/2008 | VANCL | Series D | 30M |
| 7/2017 | Kira Pharmaceuticals | Series A | 5M |
| 9/2021 | WOWJOY TECHNOLOGY | Series A | 13.6M |
| 12/2016 | Luo Tianyi | Series B | 8M |
| 4/2021 | Booming Technologies | Series C | 56M |
| 7/2018 | Wacai.com | Series D | 140M |
| 5/2019 | Nice Tuan | Series A | 27.9M |
| 1/2020 | Nice Tuan | Series B | 88.3M |
| 6/2013 | Intelligent Automation | Series A | 5.1M |
| 3/2022 | ACXEL Tech | Seed Round | 0 |
| 10/2011 | YPX Cayman Holdings | Series B | 20M |
| 2/2022 | WOWJOY TECHNOLOGY | Series A | 10M |
| 3/2018 | Chaonengjie | Seed Round | 2.8M |
| 12/2009 | LP Amina | Series B | 9.4M |
| 5/2021 | Health Biotech | Series B | 34.5M |
| 11/2020 | Yunyinggu | Series D | 45.6M |
| 5/2021 | TUNGEE | Series C | 148M |
| 9/2018 | Cubenergy Technology | Series A | 7.3M |
| 3/2015 | CashBUS | Series A | - |
| 4/2007 | Jiayuan | Series A | 5.4M |
| 4/2021 | Castbox | Series C | 15M |
| 4/2021 | Zion Pharma | Series B | 37M |
| 4/2016 | Tiebaobei | Series C | 30.9M |
| 7/2016 | LIH Investment &a; Management | Series A | 12M |
| 12/2017 | Koala Reading | Series A | 10M |
| 5/2017 | Vongi | Series A | 6M |
| 7/2014 | MEGVII | Series B | 22M |
| 6/2021 | Xiaoe Tech | Series D | 120M |
| 6/2015 | SMTP Technology | Series A | 8.1M |
| 5/2018 | The Makers | Series B | 8.5M |
| 3/2015 | Venus MedTech | Series B | 8M |
| 9/2017 | Venus MedTech | Series C | 7.4M |
| 11/2017 | Bioscience | Series C | 15.6M |
| 3/2013 | Sino MDT | Series A | 4M |
| 3/2022 | BlockVision | Seed | 5M |
| 5/2018 | Sino Biological | Venture Round | 15.8M |
| 2/2012 | Shanghai Tellgen Life Science | Series A | 5M |
| 8/2018 | Koala Reading | Series B | 20M |
| 2/2012 | Touchmedia | Series C | 16.2M |
| 3/2020 | Structure Therapeutics | Series A | 26M |
| 8/2014 | Laguo | Series B | 25M |
| 2/2020 | Kira Pharmaceuticals | Series B | 28M |
| 8/2022 | DeepWay | Series A | 67.2M |
| 9/2017 | ABC Fintech | Series A | 30M |
| 3/2018 | ACEA BIO | Series E | 15M |
| 7/2022 | Chatail | Series B | 10M |
| 7/2018 | Qingqi Technology | Angel Round | - |
| 6/2012 | Forgame | Private Equity Round | 68.8M |
| 5/2010 | 7k7k.com | Angel Round | 1.1M |
| 5/2022 | BUD | Series B | 0 |
| 12/2017 | Meituan Bike | Corporate Round | - |
| 7/2017 | OPUS | Angel Round | 1M |
| 12/2021 | DP Technology | Series B | 43.7M |
| 5/2011 | Crown Bioscience | Series C | 28.8M |
| 2/2021 | Miaoshou Doctor | Series E | 0 |
| 8/2017 | Chomp Cloud | Series A | 7M |
| 1/2016 | Zai Lab | Series B | 106.2M |
| 10/2017 | Jacobio Pharmaceuticals | Venture Round | 19.6M |
| 5/2010 | Mutto Optronics | Venture Round | - |
| 11/2018 | Guji Information | Angel Round | 287.9k |
| 11/2011 | Leho | Venture Round | 50M |
| 4/2016 | Xueda | Post-IPO Equity | - |
| 4/2007 | Huan Xiong | Venture Round | 1.8M |
| 4/2022 | Clique | Seed Round | - |
| 1/2016 | Qiniu | Series D | 100M |
| 8/2019 | RedDoorz | Series C | 0 |
| 12/2016 | MEGVII | Series C | 100M |
| 3/2016 | Lagou | Series C | 34M |
| 4/2011 | Dazhong Dianping | Series C | 100M |
| 8/2015 | Tuhu | Series C | 0 |
| 9/2019 | TigerGraph | Series B | 32M |
| 12/2019 | KeChow Pharma | Series C | 45M |
| 4/2018 | CMLabs | Series C | 15.9M |
| 7/2021 | Zion Pharma | Series B | 40M |
| 4/2014 | Arrail Dental Clinic | Series C | 70M |
| 4/2018 | Wuxi Vision Pro | Series B | 14.2M |
| 10/2013 | BSC | Series A | 1.6M |
| 10/2014 | WeDoctor | Series B | 106.5M |
| 10/2020 | Broncus Technologies | Series C | - |
| 2/2013 | Qiniu | Series B | 4.2M |
| 4/2019 | Talaris Therapeutics | Series A | 100M |
| 7/2022 | PwnedNoMore | Seed Round | - |
| 6/2020 | Miaoshou Doctor | Series D | 85M |
| 12/2017 | QwikMatch | Series B | 6M |
| 10/2018 | NASN Automotive Electronics | Series A | 14.4M |
| 1/2017 | Microtech Medical | Series B | 12.2M |
| 2/2015 | Xueba100.com | Series B | 50M |
| 6/2019 | Liuyi Jiaoyu | Series B | 2.9M |
| 5/2015 | FraudMetrix | Series B | 30M |
| 11/2021 | Allorion Therapeutics | Series A | 0 |
| 1/2022 | CureGenetics | Series B | 0 |
| 1/2017 | Xueba100.com | Series C | 100M |
| 1/2019 | Connect Biopharmaceuticals | Series B | 55M |
| 8/2021 | Berry Oncology | Series B | 99.2M |
| 6/2018 | WindMIL Therapeutics | Series B | 0 |
| 11/2018 | Cadent Therapeutics | Series B | 40M |
| 10/2018 | CardiaLen | Series B | 17M |
| 7/2019 | Yuanxin Huibao | Series A | 7.3M |
| 10/2020 | Cool Academy | Series A | 15M |
| 12/2014 | Wacai.com | Series B | 50M |
| 4/2019 | Mech-Mind | Series A | 50M |
| 3/2021 | Cool Academy | Series B | 18.9M |
| 10/2008 | Novast | Series B | 50M |
| 9/2021 | Sunyur | Series B | 0 |
| 6/2017 | MyHealthTeams | Series A | 7.3M |
| 1/2013 | Tuhu | Series A | - |
| 2/2020 | Bouffalo Lab | Series B | 26M |
| 4/2018 | XSKY Data Technology | Series C | 37.8M |
| 10/2007 | Guokang Health Management | Series A | 10M |
| 11/2017 | Berry Oncology | Series A | 121.2M |
| 8/2022 | GluBio Therapeutics | Series A | 22M |
| 9/2017 | Hypereal | Series C | 11.8M |
| 4/2013 | Shenzhen LETEL Technology | Series A | 5.9M |
| 3/2018 | DST Car | Series A | 47.8M |
| 7/2021 | Insight Lifetech | Series D | 85M |
| 12/2020 | Insight Lifetech | Series C | 27.6M |
| 6/2014 | Tujia | Series C | 100M |
| 5/2020 | Alamar Biosciences | Series A | 14M |
| 9/2012 | Mafengwo | Series B | 15M |
| 1/2022 | Ceptur Therapeutics | Series A | 0 |
| 8/2018 | TUNGEE | Series A | 6.3M |
| 6/2018 | Xiaoy Technology | Series B | 4.7M |
| 9/2011 | Beijing Centre Biology | Series A | 7.4M |
| 11/2021 | ROX Motor | Series C | 100M |
| 11/2020 | Asieris Pharmaceuticals | Series D | 0 |
| 8/2018 | Nice Tuan | Seed Round | 0 |
| 9/2011 | Beva | Series A | 3.1M |
| 9/2015 | Wealth Bridge | Series C | - |
| 12/2014 | CANbridge Pharmaceuticals | Series A | 10M |
| 9/2018 | MicroPoint Bioscience | Series E | 109M |
| 3/2021 | imToken | Series B | 30M |
| 5/2008 | Oriental Cambridge Education Group | Venture Round | 1M |
| 8/2011 | Nurotron Biotechnology | Series B | 6.9M |
| 11/2014 | Nurotron Biotechnology | Series C | 1.2M |
| 3/2022 | Medilink Therapeutics | Series B | 70M |
| 3/2019 | RedDoorz | Series B | 0 |
| 1/2017 | Shenogen Pharma Group | Series D | 45M |
| 10/2021 | ShouTi | Series B | 0 |
| 4/2021 | SinoUnited Health Clinic | Series C | 30.7M |
| 8/2014 | Qiniu | Series C | - |
| 10/2017 | Bang Er Orthopedic | Series C | 33.9M |
| 12/2018 | Microtech Medical | Series C | 29.1M |
| 1/2023 | Yike Polymers | Series B | - |
| 6/2019 | Pratilipi | Series B | 15.2M |
| 1/2022 | WoXiaoYa | Series B | - |
| 12/2019 | Newsoara | Series B | 22M |
| 7/2019 | Dingdong Maicai | Series B | - |
| 5/2019 | SinoUnited Health Clinic | Series B | 9.3M |
| 5/2018 | Heika | Series B | 10.3M |
| 6/2017 | Miaoshou Doctor | Series B | 10.9M |
| 3/2016 | JHT TCM Clinics | Series B | 1.5M |
| 4/2019 | INXX | Series B | 16.5M |
| 8/2018 | ANXIN | Series B | 19.1M |
| 4/2021 | Alpha Biopharma | Series B | 25M |
| 11/2015 | ET Healthcare | Series B | - |
| 3/2018 | Coffee Box | Series B | 88M |
| 6/2016 | CMLabs | Series B | 14.1M |
| 2/2019 | Zuiyou | Series C | 80M |
| 7/2008 | Tigermed | Series A | 6.3M |
| 7/2017 | Sino Biological | Series A | 29.4M |
| 3/2016 | Seven Kilometers | Series A | 5M |
| 12/2014 | SequoiaDB | Series A | 10M |
| 3/2019 | LuPu Investment | Series A | 44.6M |
| 3/2014 | Sanyou Medical | Series A | - |
| 12/2014 | Luoji Siwei | Series A | - |
| 1/2017 | Qkuts | Seed Round | 1M |
| 6/2018 | Pop Game | Seed Round | - |
| 2/2016 | Microtech Medical | Series A | 24.3M |
| 3/2010 | Arrail Dental Clinic | Series A | 20M |
| 12/2019 | SinoUnited Health Clinic | Series C | 8.1M |
| 11/2013 | Meitu | Seed Round | 5M |
| 12/2021 | Frontis | Seed Round | 18.4M |
| 7/2020 | XSKY Data Technology | Series D | 33M |
| 8/2021 | Neuro3 Therapeutics | Seed Round | 10M |
| 4/2018 | Meituan | Venture Round | - |
| 11/2021 | Bioyond Tech | Seed Round | 7.8M |
| 5/2013 | Berry Genomics | Series B | 14.7M |
| 7/2016 | SequoiaDB | Series B | 10M |
| 1/2008 | 9DIAMOND | Series A | 9.6M |
| 8/2010 | eHi Car Rental | Series C | 70M |
| 4/2020 | Cadent Therapeutics | Series B | 15M |
| 2/2020 | InfStones | Series A | 10M |
| 4/2022 | CIX Technology | Angel Round | - |
| 5/2017 | Wacai.com | Series C | 0 |
| 1/2021 | Vistel | Series B | 9.3M |
| 9/2019 | Amphivena Therapeutics | Series C | 0 |
| 11/2021 | Platelet BioGenesis | Series B | 75.5M |
| 7/2018 | Madaket | Series B | 0 |
| 6/2006 | Fangtek | Series C | 12M |
| 1/2015 | Bilibili | Series B | 44.2M |
| 7/2015 | Zhaolu Tianxia Wang | Series B | 3.2M |
| 7/2015 | Wacai.com | Series B | 80M |
| 7/2017 | Akulaku | Series B | 24.8M |
| 12/2020 | WT Microtech Medical | Series D | 0 |
| 1/2015 | Zhaosuliao | Series A | 20M |
| 12/2015 | HyperStrong | Series A | 20.3M |
| 4/2016 | ACEA BIO | Series E | 6M |
| 3/2013 | Origene Technologies | Series C | 21.3M |
| 6/2014 | MOGU | Series D | 200M |
| 5/2014 | Crown Bioscience | Series D | 26.6M |
| 8/2020 | Connect Biopharmaceuticals | Series C | 115M |
| 9/2021 | XellSmart | Seed Round | 11.9M |
| 1/2023 | Biotree | Series A | - |
| 2/2017 | Ark Biosciences | Series A | 8M |
| 6/2018 | Ark Biosciences | Series B | 32M |
| 4/2021 | Gaugene | Series A | 4.6M |
| 4/2019 | Coffee Box | Series B | 30.6M |
| 11/2011 | Zhihu | Series A | 8M |
| 11/2018 | WorkTrans | Series B | 23M |
| 3/2015 | Mafengwo | Series C | 100M |
| 1/2017 | Zhihu | Series D | 103.3M |
| 1/2022 | EigenCOMM | Series C | 157.3M |
| 7/2018 | Moretickets | Series C | 61.7M |
| 10/2019 | dMed | Series B | 50M |
| 1/2021 | WeRide | Series B | 0 |
| 8/2021 | Matrixport | Series C | 0 |
| 8/2013 | Shenogen Pharma Group | Series C | 20M |
| 1/2019 | NASN Automotive Electronics | Series B | 59.6M |
| 9/2020 | InventisBio | Series D | 0 |
| 5/2019 | ZuzuChe | Series C | 26.1M |
| 7/2011 | Fanli | Series A | 10M |
| 5/2021 | Valgen Medtech | Series B | 188M |
| 3/2019 | Abbisko Therapeutics | Series B | 42M |
| 5/2016 | Bilibili | Series C | 199.3M |
| 9/2019 | DST Car | Venture Round | 30M |
| 9/2008 | ChinaCache | Series C | - |
| 11/2015 | ACEA BIO | Venture Round | 30M |
| 12/2016 | WT Microtech Medical | Series B | - |
| 4/2016 | Insta360 | Series B | - |
| 9/2019 | Insilico Medicine | Series B | 37M |
| 7/2022 | Ark Biosciences | Series D | - |
| 7/2011 | Xiaomi | Series A | 41M |
| 12/2011 | Xiaomi | Series B | 90M |
| 11/2017 | Twine Health | Series A | 1.5M |
| 5/2016 | Musical.ly | Series C | 133.5M |
| 4/2008 | Nurien Software | Series A | 15M |
| 7/2011 | VANCL | Series F | 230M |
| 7/2015 | Tiebaobei | Series B | 16.2M |
| 4/2021 | Axera | Seed Round | - |
| 11/2013 | Tiebaobei | Series A | - |
| 4/2021 | Abogen Biosciences | Series B | 91.6M |
| 5/2017 | Sinocelltech | Series A | 29M |
| 12/2014 | Meitu | Series C | 190M |
| 11/2021 | GenEdit | Angel Round | 9M |
| 11/2019 | Genius | Series B | 14.2M |
| 10/2021 | Clounix | Angel Round | - |
| 7/2021 | Petkit | Series D | 60M |
| 2/2019 | Petkit | Series C | 20M |
| 9/2020 | Petkit | Series C | - |
| 6/2021 | Hesai Technology | Series D | 300M |
| 1/2022 | Zhenge Biotech | Series C | 100M |
| 10/2015 | CANbridge Pharmaceuticals | Series A | 10M |
| 2/2023 | Oricell Therapeutics | Series B | 0 |
| 3/2018 | LetsGetChecked | Series A | 12M |
| 1/2019 | Antengene Corporation | Series B | 0 |
| 2/2014 | ITutorGroup | Series B | 100M |
| 6/2009 | Novast | Series B | 25M |
| 6/2017 | Zai Lab | Series C | 30M |
| 4/2019 | Structure Therapeutics | Series A | 16M |
| 3/2023 | TandemAI | Series A | 0 |
| 8/2019 | MyHealthTeams | Series B | 0 |
| 1/2009 | Nurien Software | Series A | 10M |
| 6/2012 | Xiaomi | Series C | 216M |
| 7/2017 | Kezar Life Sciences | Series B | 0 |
| 7/2022 | Gaugene | Series B | 0 |
| 8/2021 | Abogen Biosciences | Series C | 0 |
| 1/2021 | Abbisko Therapeutics | Series D | 123M |
| 2/2022 | GluBio Therapeutics | Series A | 0 |
| 11/2015 | CanSinoBIO | Series C | 30M |
| 10/2021 | Structure Therapeutics | Series B | 0 |
| 2/2017 | Jacobio Pharmaceuticals | Series B | - |
| 4/2023 | Bioyond Tech | Series A | 0 |
| 9/2022 | XellSmart | Series A | - |
| 11/2018 | Genor Biopharma | Venture Round | 276.7M |
| 9/2018 | SequoiaDB | Series C | 0 |
| 12/2017 | Tiebaobei | Series C | - |
| 8/2022 | OriginCell | Series B | 0 |
| 12/2019 | OriginCell | Series A | 7.1M |
| 1/2019 | Schrödinger | Series E | 0 |
| 8/2017 | New Horizon Health | Series B | 20M |
| 3/2020 | Abbisko Therapeutics | Series C | 70M |
| 12/2016 | Shulan Health | Series B | 31.2M |
| 1/2023 | Singular Medical | Series B | - |
| 3/2020 | Xueba100.com | Convertible Note | 22.7M |
| 12/2019 | Clinflash Heathcare Technology | Series A | 4.3M |
| 2/2021 | Liangyihui | Series C | 0 |
| 9/2019 | Hesai Technology | Series C | 1.1M |
| 12/2016 | Finern | Series A | 7.3M |
| 1/2010 | YPX Cayman Holdings | Series A | 10M |
| 10/2008 | T4GAME | Series A | 3M |
| 3/2021 | IntoCare | Secondary Market | 4.3M |
| 3/2020 | ShouTi | Series A | 26M |
| 6/2015 | Cehome | Series B | 2.5M |
| 1/2016 | HyperStrong | Series B | 68.5M |
| 5/2014 | Broncus Technologies | Venture Round | 4.3M |
| 6/2021 | BrainHealth | Series C | 72.4M |
| 12/2018 | Xiudan | Seed Round | 3M |
| 4/2018 | KangBai | Series A | 3.7M |
| 3/2015 | Bioon.com | Series A | 2.9M |
| 2/2021 | Wholee | Series A | 10k |
| 12/2021 | Clinflash Heathcare Technology | Venture Round | 15.5M |
| 5/2018 | Bang Er Orthopedic | Series C | 15.8M |
| 3/2021 | Basecamp Bio | Angel Round | 14M |
| 8/2021 | Yunqi | Seed Round | 31M |
| 7/2013 | Hortor | Series A | 2.5M |
| 12/2021 | Sinogen Biopharma | Venture Round | 3M |
| 11/2018 | Mucho Indonesia | Seed Round | 3M |
| 9/2021 | ROX Motor | Series B | 60M |
| 12/2011 | Beijing GoodWill Technology | Series A | 4.2M |
| 6/2022 | Insilico Medicine | Series D | 0 |
| 5/2019 | Zaojiu | Venture Round | 2M |
| 12/2019 | Inbilin | Venture Round | - |
| 8/2021 | Lingyi Zhihui | Series B | 0 |
| 5/2017 | DST Car | Seed Round | 7.3M |
| 11/2018 | Webuy Group | Series B | 15.8M |
| 8/2016 | Xiutao | Seed Round | 1.5M |
| 10/2015 | Wuxi Vision Pro | Series A | 4.8M |
| 11/2018 | WebComics | Seed Round | 3.2M |
| 9/2018 | Aohua | Series D | 43.7M |
| 9/2019 | Plum | Series B | 0 |
| 1/2016 | Aohua | Series C | 30.8M |
| 7/2015 | Lanmi | Series A | 5M |
| 3/2018 | V Light | Seed Round | 1M |
| 6/2013 | VINNO Technology | Series A | 5.8M |
| 4/2022 | Rhino Health | Venture Round | 5.7M |
| 8/2017 | Antengene Corporation | Series A | 21M |
| 7/2020 | New Horizon Health | Series E | 30M |
| 7/2010 | Sangon Biotech | Series A | 6.2M |
| 7/2018 | dMed | Series B | 6M |
| 1/2020 | Chushou | Debt Financing | 4M |
| 3/2019 | ACEA BIO | Venture Round | 20M |
| 1/2018 | Chushou | Series D | 47.5M |
| 2/2017 | Anssure Pharma | Series A | 8.7M |
| 2/2017 | Anxin Doctor | Series B | 29.1M |
| 4/2021 | Unisound | Series D | 60M |
| 4/2020 | Belief Biomed | Series B | 84M |
| 9/2017 | VR Medical | Series B | 3M |
| 9/2019 | Tisenc | Series B | 11.2M |
| 3/2008 | Touchmedia | Series B | 14.2M |
| 2/2021 | Saints Sages Medical | Series A | 18.6M |
| 3/2015 | Insta360 | Series A | 8M |
| 11/2021 | Micropace | Series A | 5.5M |
| 8/2006 | Touchmedia | Series A | - |
| 8/2018 | APT Medical | Series B | 11.1M |
| 8/2018 | Cool Math | Series A | 10M |
| 1/2005 | Gammastar Medical Group | Series A | 8.7M |
| 5/2010 | ChinaCache | Post-IPO Equity | - |
| 5/2021 | IntoCare | Series D | 43.2M |
| 10/2013 | Dajiabao | Series A | - |
| 11/2021 | Beijing Okeanos Technology | Series B | 22.4M |
| 5/2021 | Data Transmission Group | Secondary Market | 9.3M |
| 12/2017 | Cehome | Series D | 44M |
| 8/2021 | Superhexa | Seed Round | 9.9M |
| 12/2021 | Superhexa | Series A | 28M |
| 9/2007 | Juren Educational | Venture Round | 20M |
| 12/2013 | Shanghai Rendu Biotechnology | Series B | 10.3M |
| 8/2022 | Oricell Therapeutics | Series B | 120M |
| 10/2017 | SGEET | Series A | 7.5M |
| 5/2014 | Meitu | Series B | 115M |
| 12/2019 | Yuanxin Huibao | Series A | 4.3M |
| 7/2018 | ZEGOCLOUD | Series B | 16M |
| 8/2017 | Kintep Environmental | Series B | 5.6M |
| 8/2022 | GluBio Therapeutics | Series A | 0 |
| 8/2022 | OriginCell | Series B | 0 |
| 8/2022 | Oricell Therapeutics | Series B | 0 |
| 7/2022 | Chatail | Series B | 0 |
| 7/2022 | CIX Technology | Seed Round | - |
| 7/2022 | Biotree | Series A | 0 |
| 7/2022 | Gaugene | Series B | 0 |
| 7/2022 | Ark Biosciences | Series D | - |
| 6/2022 | LaNova Medicines | Series B | - |
| 6/2022 | Insilico Medicine | Series D | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
